OptimizeRx to Participate at Lake Street Annual Best Ideas Growth Conference on September 12, 2019
The company’s digital health network is expanding into the acute care market after reaching more than half of the ambulatory patient market in the U.S.
The BIG3 event brings together more than 60 dynamic small-cap publicly traded company management teams to interact with over 100 institutional accounts from across the country in a one-on-one meeting format.
The event is for institutional clients of Lake Street and is by invitation only. To schedule a one-on-one meeting with
The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest, and directly via its mobile communications platform.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Tel (248) 651-6568 x807
Media Relations Contact
Nicole Brooks, Innsena Communications
Tel (860) 800-2344
Investor Relations Contact
Tel (949) 432-7557
Source: OptimizeRx Corporation